The New York Times @nytimes
A panel of advisers to the CDC has been discussing the details of who qualifies for a Pfizer-BioNTech booster shot and why. A decision is expected on Thursday. https://t.co/31s29tKU4b — PolitiTweet.org
Created
Thu Sep 23 13:00:08 +0000 2021
Likes
86
Retweets
22
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The New York Times @nytimes
A panel of advisers to the CDC has been discussing the details of who qualifies for a Pfizer-BioNTech booster shot and why. A decision is expected on Thursday. https://t.co/31s29tKU4b — PolitiTweet.org